Last reviewed · How we verify

prednison, Azenil

Tel-Aviv Sourasky Medical Center · FDA-approved active Small molecule

Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.

Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic reactions and asthma, Adrenal insufficiency.

At a glance

Generic nameprednison, Azenil
SponsorTel-Aviv Sourasky Medical Center
Drug classCorticosteroid (glucocorticoid)
TargetGlucocorticoid receptor (GR)
ModalitySmall molecule
Therapeutic areaImmunology, Rheumatology, Allergy, Endocrinology
PhaseFDA-approved

Mechanism of action

Prednisone acts as a glucocorticoid receptor agonist, translocating to the nucleus and modulating gene expression to decrease production of pro-inflammatory cytokines and immune cell activation. It reduces inflammation, suppresses immune responses, and has broad anti-inflammatory effects across multiple organ systems. This makes it useful for treating autoimmune, inflammatory, and allergic conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: